| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 45, 941-947, May 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology
Departments of Internal Medicine and Radiology, Washington University School of Medicine, St. Louis, MO
1 To whom correspondence should be addressed. e-mail: gschonfe{at}wustl.edu
Fatty liver is frequent in the apolipoprotein B (apoB)-defective genetic form of familial hypobetalipoproteinemia (FHBL), but interindividual variability in liver fat is large. To explain this, we assessed the roles of metabolic factors in 32 affected family members with apoB-defective FHBL and 33 related and unrelated normolipidemic controls matched for age, sex, and indices of adiposity. Two hour, 75 g oral glucose tests, with measurements of plasma glucose and insulin levels, body mass index, and waist-hip ratios were obtained. Abdominal subcutaneous, intraperitoneal (IPAT), and retroperitoneal adipose tissue masses were quantified by MR imaging, and hepatic fat was quantified by MR spectroscopy. Mean ± SD liver fat percentage values of FHBL and controls were 14.8 ± 12.0 and 5.2 ± 5.9, respectively (P = 0.001). Means for these measures of obesity and insulin action were similar in the two groups. Important determinants of liver fat percentage were FHBL-affected status, IPAT, and area under the curve (AUC) insulin in both groups, but the strongest predictors were IPAT in FHBL (partial R2 = 0.55, P < 0.0002) and AUC insulin in controls (partial R2 = 0.59, P = 0.0001). Regression of liver fat percentage on IPAT fat was significantly greater for FHBL than for controls (P < 0.001).
In summary, because apoB-defective FHBL imparts heightened susceptibility to liver triglyceride accumulation, increasing IPAT and insulin resistance exert greater liver fat-increasing effects in FHBL.
Supplementary key words abdominal adipose tissue • insulin resistance • apolipoprotein B
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. van der Graaf, S. W. Fouchier, M. N. Vissers, J. C. Defesche, A. Wiegman, R. R. Sankatsing, B. A. Hutten, M. D. Trip, and J. J.P. Kastelein Familial Defective Apolipoprotein B and Familial Hypobetalipoproteinemia in One Family: Two Neutralizing Mutations Ann Intern Med, May 6, 2008; 148(9): 712 - 714. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Burnett, S. Zhong, Z. G. Jiang, A. J. Hooper, E. A. Fisher, R. S. McLeod, Y. Zhao, P. H. R. Barrett, R. A. Hegele, F. M. van Bockxmeer, et al. Missense Mutations in APOB within the beta{alpha}1 Domain of Human APOB-100 Result in Impaired Secretion of ApoB and ApoB-containing Lipoproteins in Familial Hypobetalipoproteinemia J. Biol. Chem., August 17, 2007; 282(33): 24270 - 24283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Hooper, K. Robertson, P. H. R. Barrett, K. G. Parhofer, F. M. van Bockxmeer, and J. R. Burnett Postprandial Lipoprotein Metabolism in Familial Hypobetalipoproteinemia J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1474 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-L. Zhang, A. Hernandez-Ono, P. Siri, S. Weisberg, D. Conlon, M. J. Graham, R. M. Crooke, L.-S. Huang, and H. N. Ginsberg Aberrant Hepatic Expression of PPAR{gamma}2 Stimulates Hepatic Lipogenesis in a Mouse Model of Obesity, Insulin Resistance, Dyslipidemia, and Hepatic Steatosis J. Biol. Chem., December 8, 2006; 281(49): 37603 - 37615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Sankatsing, S. W. Fouchier, S. de Haan, B. A. Hutten, E. de Groot, J. J.P. Kastelein, and E. S.G. Stroes Hepatic and Cardiovascular Consequences of Familial Hypobetalipoproteinemia Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1979 - 1984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Lin, P. Yue, Z. Chen, and G. Schonfeld Hepatic triglyceride contents are genetically determined in mice: results of a strain survey Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1179 - G1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Whitfield, P. H. R. Barrett, K. Robertson, M. F. Havlat, F. M. van Bockxmeer, and J. R. Burnett Liver Dysfunction and Steatosis in Familial Hypobetalipoproteinemia Clin. Chem., January 1, 2005; 51(1): 266 - 269. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
